APA (7th ed.) Citation

DL, W., MS, K., S, F., R, S., J, B., SR, K., . . . CB, S. (2021). Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials. Dove Medical Press.

Chicago Style (17th ed.) Citation

DL, Wirta, Korenfeld MS, Foster S, Smyth-Medina R, Bacharach J, Kannarr SR, Jaros MJ, and Slonim CB. Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials. Dove Medical Press, 2021.

MLA (8th ed.) Citation

DL, Wirta, et al. Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials. Dove Medical Press, 2021.